Coronavirus (2021) thread

[johnnytapia]

Though illegal wars tend to taint it.

Absolutely but he was an election winning machine. But yes, tainted by Iraq undoubtedly

 

[The Northern Baptist]

It’s official then that the new variant is 50% less severe. Thank you BJ for your strong leadership and resisting the calls from the MSM to lock down. Hoping you all have a wonderful covid free Xmas.

 

[ZenHalfTimeCrock]

The reality is that the NHS has been run-down for decades and perhaps will never be able to cope with such a huge longer-living demographic. All my family members believe that radical reform and modernisation is required. I don't think any of them want "wholesale privatisation" but they are open to a debate about some of the sacred cows such as charging people a small fee for a GP's appointment to deter people from not turning up. They all say that it is incredibly badly managed and is probably just too big to ever be efficient. None of them thinks that just "throwing money at the problem" is a long-term solution though the NHS does need some more investment.
For example I have heard one relative (a GP) say that the entire function of the GP needs to change. There is too much overlap with Pharmacists and Nurse Practicioners should play a bigger role. As a general rule there is too much job demarcation and not enough flexibiility. Algorithms can diagnose some illnesses very efficiently but there is a lot of protectionism and some people are not willing to modernise. The processes in many cases are 30 years out of date. Some hospital consultants still insist on paper letters being written to them for example. It is a bloody mess and no politicians of any party have been prepared to sort it out.

Many thanks for replying in such detail. Sounds spot-on to me.

 

[SWP's back]

It’s official then that the new variant is 50% less severe. Thank you BJ for your strong leadership and resisting the calls from the MSM to lock down. Hoping you all have a wonderful covid free Xmas.

At least 50% less severe. SA data suggests it’s 25x less deadly.

 

[Betterdeedthan red]

I don’t think covid has been 5% as polarising and divisive as Brexit.

The vast, vast majority are provaccine and prepared to just follow the guidance. Anti-vac and anti-lockdown (at least up to Omicron) have been an incredibly fringe view - as evidenced by the huge vaccine numbers and how diligently the lockdowns were followed.

People's opinions are changing after this omicron bollocks though

 

[Gabriel]

Gordon Brown pressing for more vaccines to be sent to the developing world so as to stave off future variants, a call supported by the WHO. Fully agree but people need to be told that many doses are going to waste on account of vaccine hesitancy. The developed world can send as much as it can in 2022, but if that isn’t accompanied with an enormous education programme, then we might all be goosed.

 

[Gabriel]

Promising results of a small Phase II Israeli study that appears to stop hospitalised patients deteriorating.

 

[Johnny Mars Bar]

"Frankly, if you're not vaccinated at the moment and you're eligible and you've got no health reason for not being vaccinated, you're not just irresponsible, you're an idiot. "I'm sorry. Truthfully you are."

Tony Blair not mincing his words today

He has forgotten more about leadership than any of this current shower of shite will ever know in their lifetime.

 

[SWP's back]

Promising results of a small Phase II Israeli study that appears to stop hospitalised patients deteriorating.

Sounds like it could be game over for covid also (in terms of the illness dictating policy and economic performance).

 

[waspish]

Promising results of a small Phase II Israeli study that appears to stop hospitalised patients deteriorating.

Israeli drug prevents 100% of COVID patients from deteriorating in trial

All 18 hospitalized individuals administered the treatment developed by Israeli biotech company Amorphical in a phase II trial recovered and were discharged in a few days.

Medical personnel work at the Intensive Care Unit (ICU) for COVID-19 patients at the Emile Muller GHRMSA hospital in Mulhouse, France, December 16, 2021 (photo credit: REUTERS/YVES HERMAN/FILE PHOTO)
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
The trial was conducted at the Ziv Medical Center in Safed and led by the directors of the coronavirus department, Dr. Kamal Abu Jabal and Dr. Nashat Abu Saleh. As part of compassionate care, two other patients in a very serious condition were given the drug and they both recovered and were discharged.

Top Articles By JPost

Hospital stay risk for Omicron is 40%-45% lower than Delta - UK study

“Since the patients treated with the drug recovered within a few days and were released to their home, this was 100% successful,” Abu Saleh said.

Amor-18, which uses Amorphous Calcium Carbonate (ACC) as the main ingredient, was administered orally or by inhalation. As explained by the company, ACC has the ability to modulate acidic pH changes around each cell. These changes affect the capability of the coronavirus to penetrate the cells and replicate. This allows the drug to prevent the virus from spreading and therefore the patients from deteriorating.

“We are excited about the results of the clinical trial, which bring real hope to corona patients in Israel and around the world, and are especially encouraging these days with the start of the fifth wave and the Omicron variant,” said Amorphical CEO Yossi Ben.
Colorized scanning electron micrograph of an apoptotic cell (purple) infected with SARS-COV-2 virus particles (yellow), also known as novel coronavirus, isolated from a patient sample. (credit: NIH/HANDOUT VIA REUTERS)Colorized scanning electron micrograph of an apoptotic cell (purple) infected with SARS-COV-2 virus particles (yellow), also known as novel coronavirus, isolated from a patient sample. (credit: NIH/HANDOUT VIA REUTERS)
“The drug we have developed is anti-inflammatory, safe and effective and it is easy to use,” he also said, adding that Amor-18 will work against the entire SARS virus family, including all COVID variants.

A larger trial is already being conducted at the Ziv, Shamir, Kaplan and Maayan Hayeshua medical centers in Israel. In the near future, the drug is also going to be tested in other countries. Seven hospitals in Brazil have already announced they will participate, and other centers in Europe and the United States are expected to join soon.

 

[Craig]

He has forgotten more about leadership than any of this current shower of shite will ever know in their lifetime.

Great leader but utter **** of a man with no conscience. Been a few great leaders like that down the years to be fair.

 

[Gabriel]

Sounds like it could be game over for covid also (in terms of the illness dictating policy and economic performance).

I’d like to think so. I think we’ll be better equipped going into 2022, both in terms of vaccines and antivirals, but I still think we’ll need to come to terms with our psychological issues. We’re so cocooned and cautious now that I don’t think we’ll see any plasters being ripped off quite yet. Always thought that this Christmas would be ‘lost’ but am increasingly confident that February might prove the month when we start seeing a return to normality. But where does Delta go?

 

[Rammy Blue]

Israeli drug prevents 100% of COVID patients from deteriorating in trial

All 18 hospitalized individuals administered the treatment developed by Israeli biotech company Amorphical in a phase II trial recovered and were discharged in a few days.

Medical personnel work at the Intensive Care Unit (ICU) for COVID-19 patients at the Emile Muller GHRMSA hospital in Mulhouse, France, December 16, 2021 (photo credit: REUTERS/YVES HERMAN/FILE PHOTO)
All 18 COVID-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
The trial was conducted at the Ziv Medical Center in Safed and led by the directors of the coronavirus department, Dr. Kamal Abu Jabal and Dr. Nashat Abu Saleh. As part of compassionate care, two other patients in a very serious condition were given the drug and they both recovered and were discharged.

Top Articles By JPost

Hospital stay risk for Omicron is 40%-45% lower than Delta - UK study

“Since the patients treated with the drug recovered within a few days and were released to their home, this was 100% successful,” Abu Saleh said.

Amor-18, which uses Amorphous Calcium Carbonate (ACC) as the main ingredient, was administered orally or by inhalation. As explained by the company, ACC has the ability to modulate acidic pH changes around each cell. These changes affect the capability of the coronavirus to penetrate the cells and replicate. This allows the drug to prevent the virus from spreading and therefore the patients from deteriorating.

“We are excited about the results of the clinical trial, which bring real hope to corona patients in Israel and around the world, and are especially encouraging these days with the start of the fifth wave and the Omicron variant,” said Amorphical CEO Yossi Ben.
Colorized scanning electron micrograph of an apoptotic cell (purple) infected with SARS-COV-2 virus particles (yellow), also known as novel coronavirus, isolated from a patient sample. (credit: NIH/HANDOUT VIA REUTERS)Colorized scanning electron micrograph of an apoptotic cell (purple) infected with SARS-COV-2 virus particles (yellow), also known as novel coronavirus, isolated from a patient sample. (credit: NIH/HANDOUT VIA REUTERS)
“The drug we have developed is anti-inflammatory, safe and effective and it is easy to use,” he also said, adding that Amor-18 will work against the entire SARS virus family, including all COVID variants.

A larger trial is already being conducted at the Ziv, Shamir, Kaplan and Maayan Hayeshua medical centers in Israel. In the near future, the drug is also going to be tested in other countries. Seven hospitals in Brazil have already announced they will participate, and other centers in Europe and the United States are expected to join soon.

Wow, early days of course, but that sounds like it could be what we are looking for. Also sure it can be replicated in similar drugs too.

 

[Invisible Man's Bandage]

What I assume is still skewing the figures for hospitalisations in particular is the fact that there are still high numbers of Delta cases in large parts of the country. It does seems clear that Omicron is both more transmissible but less severe than Delta. Hopefully Omicron will replace Delta more or less entirely very quickly and then we are dealing with one varient and not two.

Hospitalisations appear to have increased a bit in London but it is also a fact that vaccination levels are relatively low there so that is to be expected (Manchester and Liverpool are similar too). However, vaccination levels are much higher outside the major cities and so you'd expect much stronger protection in those populations and hence less hospitalisations.

With luck, the end game is a rapid surge of cases mainly in the unvaccinated/part vaccinated cohort but with manageable numbers of hospitalisations resulting in the elusive herd immunity. The very rapid booster rollout is also a huge positive so I believe we are in a very good position with the caveat that it may be a tricky month or so upcoming.

2022 will be a better year.

 

[hilts]

One things for certain, covid in all it’s guise’s is the most divisive subject I’ve ever known or heard of, the difference in views is staggering, the belief in these views is akin to the onset of civil war.
To the front lads, ur country needs you, forget north south divide this is beyond.
My family are torn apart, my work colleagues are torn apart, no fucker knows the answers but all believe we do.
One day my friends we shall have unification and an allegiance together, til then do what you need to in your own beliefs and let live.

It's a barm

 

[True_Blue69]

What I assume is still skewing the figures for hospitalisations in particular is the fact that there are still high numbers of Delta cases in large parts of the country. It does seems clear that Omicron is both more transmissible but less severe than Delta. Hopefully Omicron will replace Delta more or less entirely very quickly and then we are dealing with one varient and not two.

Hospitalisations appear to have increased a bit in London but it is also a fact that vaccination levels are relatively low there so that is to be expected (Manchester and Liverpool are similar too). However, vaccination levels are much higher outside the major cities and so you'd expect much stronger protection in those populations and hence less hospitalisations.

With luck, the end game is a rapid surge of cases mainly in the unvaccinated/part vaccinated cohort but with manageable numbers of hospitalisations resulting in the elusive herd immunity. The very rapid booster rollout is also a huge positive so I believe we are in a very good position with the caveat that it may be a tricky month or so upcoming.

2022 will be a better year.

What people are in hospital for is key though. Naturally, as more of the population catch it the numbers of people with it in hospital will increase. If 50% of the population have it, then 50% of people admitted to hospital will have it. The stat last week was a big chunk were in for something totally different.

I expect omicron to prove to be even less of a threat as the weeks go by. I know so many that have caught it in the last week and not one has any semblance of an illness. Previous waves the majority I know were ill and bed bound for at least a few days and I know a couple who ended up in hospital.

 

[hilts]

Breaking this morning on radio 2 news, some bloke said omicron appears milder but more transmissible. More should be known in the next few days.

The NHS could come under pressure he stated(state sponsored sickies will do that mind)

Turn off the news its just a repeat and enjoy Xmas and hopefully new year blues.

 

[Gabriel]

Breaking news this morning on radio 2 news, some bloke said omicron appears milder but more transmissible. More should be known in the next few days.

The NHS could come under pressure he stated(state sponsored sickies will fo that mind)

Turn off the news its just a repeat and enjoy Xmas and hopefully new year blues.

Alternatively, listen to a different radio station and still enjoy Christmas. ;-)

 

[hilts]

Alternatively, listen to a different radio station and still enjoy Christmas. ;-)

They all do the news I'm afraid. Plus dab can be a right load of shit. Sometimes I'm stuck with Jeremy Vine and a tomato growing Welsh bloke.

People think the virus is a problem, welcome to my world;-)

 

[hammocity]

What I assume is still skewing the figures for hospitalisations in particular is the fact that there are still high numbers of Delta cases in large parts of the country. It does seems clear that Omicron is both more transmissible but less severe than Delta. Hopefully Omicron will replace Delta more or less entirely very quickly and then we are dealing with one varient and not two.

Hospitalisations appear to have increased a bit in London but it is also a fact that vaccination levels are relatively low there so that is to be expected (Manchester and Liverpool are similar too). However, vaccination levels are much higher outside the major cities and so you'd expect much stronger protection in those populations and hence less hospitalisations.

With luck, the end game is a rapid surge of cases mainly in the unvaccinated/part vaccinated cohort but with manageable numbers of hospitalisations resulting in the elusive herd immunity. The very rapid booster rollout is also a huge positive so I believe we are in a very good position with the caveat that it may be a tricky month or so upcoming.

2022 will be a better year.

A lot of positivity on BM today, great to read.